Day: September 23, 2021

Soleno Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference

Written by Customer Service on September 23, 2021. Posted in Public Companies.

REDWOOD CITY, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on Thursday, September 30, 2021 at 2:40 PM Eastern Time. A live audio webcast and replay of the presentation will be available in the Investors section on the Company’s website at www.soleno.life. About Soleno Therapeutics, Inc.Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, DCCR extended-release tablets, a once-daily oral tablet for the treatment of Prader-Willi...

Proactive news headlines including Arrow Minerals, Technology Metals Australia, High Peak Royalties and Marvel Gold

Written by Customer Service on September 23, 2021. Posted in Mergers And Acquisitions.

Sydney, Sept. 23, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Arrow Minerals Ltd (ASX:AMD) has highlighted a transformative 12 months ending June 30, 2021, with the company entering into several commercial agreements to acquire access to high-quality exploration permits, divesting non-core assets whilst retaining value options and growing the technical capability of the team. Click here Technology Metals Australia Ltd (ASX:TMT) has attracted a new cornerstone investor in Resource Capital Fund VII LP, a fund managed by RCF Management LLC, as part of a placement that will raise $20 million. Click here High Peak Royalties Ltd (ASX:HPR) is now in a trading halt pending news on the completion of a capital raising effort. Click...

TG Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference

Written by Customer Service on September 23, 2021. Posted in Public Companies.

Fireside chat scheduled for 10:40 AM ET on Monday, September 27, 2021 NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in a fireside chat during the 2021 Cantor Virtual Healthcare Conference, taking place September 27 – 30, 2021. The fireside chat is scheduled to take place on Monday, September 27, 2021 at 10:40 AM ET. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company’s website at http://ir.tgtherapeutics.com/events. A replay of the webcast will be available on TG’s website following the event. ABOUT TG THERAPEUTICS, INC.TG Therapeutics is a fully-integrated, commercial stage biopharmaceutical company...

Sio Gene Therapies to Participate in Upcoming Conferences

Written by Customer Service on September 23, 2021. Posted in Public Companies.

NEW YORK and RESEARCH TRIANGLE PARK, N.C., Sept. 23, 2021 (GLOBE NEWSWIRE) — Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically improve the lives of patients with neurodegenerative diseases, announced today that the company will participate in select upcoming investor and scientific conferences. Details can be found below. Cantor Fitzgerald Global Healthcare ConferenceParticipation: PresentationPresenter:Date:Time: Webcast Link: Pavan Cheruvu, MD, Chief Executive OfficerMonday, September 27th10:00 AM EThttps://wsw.com/webcast/cantor12/siox/2117150Chardan Genetic Medicines ConferenceParticipation: PresentationPresenter:Date:Time: Webcast Link: Pavan Cheruvu, MD, Chief Executive OfficerTuesday, October 5th9:00 AM EThttps://wsw.com/webcast/chard9/siox/1887025Alliance...

Plus Therapeutics to Present Rhenium-186 NanoLiposome Data at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting

Written by Customer Service on September 23, 2021. Posted in Public Companies.

AUSTIN, Texas, Sept. 23, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced it will present data regarding its Rhenium-186 NanoLiposome (186RNL) investigational radiotherapeutic for recurrent glioblastoma (GBM) at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting being held in person October 24-27, 2021 in Chicago, Illinois. Details of the abstract and poster viewing Q&A session are as follows:Title Image-guided Rhenium-186 NanoLiposome (186RNL) brachytherapy in the treatment of recurrent glioblastoma: technique, image analysis, dosimetry, and monitoringDate October 27, 2021 at 1:00 p.m. CT / 2:00 p.m. ETLocation McCormick...

FTI Consulting’s Naidira Alemova Named to Crain’s Fourth Annual Notable Women in Accounting and Consulting List

Written by Customer Service on September 23, 2021. Posted in Public Companies.

WASHINGTON, Sept. 23, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that Naidira Alemova, a Senior Managing Director within the firm’s Forensic and Litigation Consulting segment, has been named to Crain’s fourth annual list of Notable Women in Accounting and Consulting. Ms. Alemova, who has been named to the list for two consecutive years, was among 67 women recognized across the New York City area. The award recognizes women professionals for their career achievements in accounting and consulting. Ms. Alemova is a member of the Financial Services practice at FTI Consulting and has more than 20 years of experience in banking and securities regulatory matters, including investigations of money laundering, financial crime, bribery and corruption. Her experience covers the execution of anti-money laundering...

Vivos Therapeutics Announces Formation of New Medical Consortium to Advance the Company’s Technology for Obstructive Sleep Apnea

Written by Customer Service on September 23, 2021. Posted in Public Companies.

Drs. Clete Kushida of Stanford and Cecilia Wu of University of Alberta to lead a team of prominent, multi-disciplinary medical doctors guiding research and fostering increased physician-dental collaboration in the management of obstructive-sleep apnea HIGHLANDS RANCH, Colo., Sept. 23, 2021 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (OSA) and snoring, announced today the official formation of the Vivos Medical Consortium. This physician working group will collaborate to advance Vivos’ OSA technology capabilities and includes renowned physicians with specialties in sleep medicine, neurology, pediatrics, pulmonology, anesthesiology,...

Mindset Pharma Announces Inclusion in NYSE Listed AdvisorShares Psychedelics Exchange Traded Fund (ETF)

Written by Customer Service on September 23, 2021. Posted in Public Companies.

TORONTO, Sept. 23, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs, today announced that it has been included in the AdvisorShares Psychedelics ETF traded on the NYSE Arca under the ticker symbol “PSIL.” PSIL is an actively managed exchange-traded product that invests in the emerging psychedelic drugs sector. The PSIL offers exposure to biotechnology, pharmaceutical and life sciences companies deriving the majority of their net revenue or devoting the majority of their assets to psychedelic drugs, and only holds companies that they see as leading the way in...

(OMHI) – OM Holdings International Inc. Announces 20 Year Exclusive Rights to Rydeum’s DoGetGo Mobile App for the $4.6B Food Delivery and Taxi Market in the Caribbean

Written by Customer Service on September 23, 2021. Posted in Public Companies.

MIAMI, FL, Sept. 23, 2021 (GLOBE NEWSWIRE) — OM Holdings International Inc. (OTC PINK: OMHI), an owner and operator of OneMart super merchandising stores and Builders Depot in the British Virgin Islands, and the parent of its technology subsidiary Rydeum Caribbean, today announced it has retained exclusive rights to Rydeum’s DoGetGo mobile app for 20 years. The agreement will allow OMHI to have exclusive rights to generate revenue from any user that utilizes the app within 28 Caribbean Countries for the next 20 years. The DoGetGo mobile app will primarily target the $4.6B food delivery and taxi market in the Caribbean. It is anticipated that the app will be rolled out in Jamaica before the end of the year. It is the first app adopted by the Jamaican Union of Travelers Association (JUTA), which boasts 12,000 drivers. JUTA represents...

Midland Begins Stripping Program on Its New Golden Nest Gold Showing Discovered on Lewis

Written by Customer Service on September 23, 2021. Posted in Public Companies.

Figure 1Abitibi Geology-Midland Gold ProjectsFigure 2Lewis Project LocationFigure 3Lewis Geology and New 2020-21 DiscoveryFigure 4Lewis MAG TD and New 2020-21 DiscoveryFigure 5IP Ore-Vision SurveyFigure 6IP Chargeability Map and TargetsFigure 7Golden Nest New ShowingFigure 8Golden Nest Sample A0358475Figure 9Golden Nest Sample A0361223MONTREAL, Sept. 23, 2021 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland” or the “Corporation”) (TSX-V: MD) is pleased to report the start of a stripping program on its new Golden Nest gold showing discovered in the summer of 2021 on its Lewis project, wholly owned by Midland and located approximately 60 kilometres southwest of the town of...

Day: September 23, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice